Variables | Osteoporosis | Â | Sarcopenia | Â |
---|---|---|---|---|
OR(95% CI) | P value | OR(95% CI) | P-value | |
History of fragile fracture (no vs. fracture) | 0.30 (0.05–0.71) | 0.006 | 0.45 (0.01–0.86) | 0.015 |
Physical exercise (no vs. high) | 0.97 (0.44–3.13) | 0.94 | 1.07 (0.24–2.51) | 0.69 |
Milk consumption (no vs. high) | 1.39 (0.57–3.34) | 0.46 | 6.32 (1.04–38.29) | 0.045 |
DHEA (ng/ml) | 0.75 (0.61–1.05) | 0.06 | 0.73 (0.51–0.96) | 0.032 |
 T2 | 0.89 (0.63–1.24) | 0.62 | 0.78 (0.44–2.22) | 0.72 |
 E2 | 0.67 (0.33–2.65) | 0.58 | 0.90 (0.46–3.12) | 0.65 |
 PTH (pg/ml) | 1.01 (0.97–1.04) | 0.64 | 0.97 (0.90–1.04) | 0.36 |
25OHD(ng/ml) | 0.98 (0.93–1.07) | 0.22 | 0.51 (0.11–0.82) | 0.047 |
 CTX (pg/ml) | 1.02 (0.98–1.05) | 0.17 | 1.02 (0.92–1.12) | 0.78 |
 PINP (ng/ml) | 1.12 (0.97–1.48) | 0.51 | 1.07 (0.95–1.17) | 0.31 |
Follistatin (ng/ml) | 1.08 (0.56–2.09) | 0.17 | 1.66 (1.19–3.57) | 0.022 |
 Myostatin (ng/ml) | 0.95 (0.90–1.13) | 0.82 | 1.01 (0.98–1.03) | 0.56 |
 BDNF (ng/ml) | 0.78 (0.38–1.62) | 0.50 | 0.35 (0.07–1.82) | 0.35 |
Oxytocin (pg/ml) | 0.75 (0.63–0.98) | 0.019 | 0.88 (0.57–1.01) | 0.14 |